Abivax S.A.

Biotechnology • Healthcare • Paris, France • AAVXF (PNK)

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

33 1 53 83 09 63 7-11 boulevard Haussmann, France

Stock Performance (90 Days)

Data through May 15, 2026

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

ABVX Stock Chart | ABIVAX SA-ADR (NASDAQ:ABVX) - ChartMill

ChartMill • May 13

Total Clarity Wealth Management Inc. Acquires Shares of 9,245 Abivax SA Sponsored ADR $ABVX - MarketBeat

MarketBeat • May 1

Abivax investors sign off on 2025 results, pay and financing powers - Stock Titan

Stock Titan • May 11

Why Abivax SA Sponsored ADR Shares Keep Sliding - TipRanks

TipRanks • Apr 27

Abivax CEO Says Big Pharma Can’t Ignore Its Experimental Drug - Bloomberg.com

Bloomberg.com • Jan 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Abivax S.A. had layoffs?

No layoff events have been recorded for Abivax S.A. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Abivax S.A. have?

Abivax S.A. has approximately 67 employees.

What industry is Abivax S.A. in?

Abivax S.A. operates in the Biotechnology industry, within the Healthcare sector.

Is Abivax S.A. a publicly traded company?

Yes, Abivax S.A. is publicly traded under the ticker symbol AAVXF on the PNK. The company has a market capitalization of approximately $9.26 billion.

Where is Abivax S.A. headquartered?

Abivax S.A. is headquartered in Paris, France at 7-11 boulevard Haussmann, France.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.